Interview with Timothy Kedijang, General Manager, Novo Nordisk South Africa
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of…
Novo Nordisk South Africa
Last updated: 13.02.2014
Address: 2nd Floor, Building A
345 Rivonia Boulevard
Edenburg, Rivonia
Sandton 2128
South Africa
Tel: +27 (11) 202-0500
Web: http://www.novonordisk.com/
Company description
Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs more than 29,300 employees in 76 countries, and markets its products in 179 countries.
Products and services
Novo Nordisk is a focused healthcare company and a world leader in diabetes care.
We believe action defines leadership.
The status quo is just not good enough. We are actively working to change the course of the diabetes pandemic, improve the daily lives of people with diabetes, and to expand the possibilities for people with hemophilia. Innovation and personal passion are the hallmarks of how we operate.
Our company’s history is full of firsts, and we will continue to tap that well of innovation to not only develop ever-more effective treatment options for the patients we serve but also innovation in education, leadership and advocacy.
Personal passion about the well-being of people with chronic illness has always been at the heart of our company. Our roots reach far back to a man driven to find an innovative treatment for his wife, in 1923.
We carry that same passion and commitment beyond diabetes into our work for people with haemophilia, growth disorders and women requiring hormone therapy.
Since that start, the company’s care for the individual’s well-being blossomed into a deep sense of responsibility for all of society. An early adopter of the triple bottom line approach to business, Novo Nordisk remains a leading proponent of balancing its environmental impact, social contribution and financial results.
Interviews
Related
South Africa / Aspen Inks Deal to Manufacture J&J’s COVID-19 Vaccine
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
Opinion / Malaria Prevention Cannot be Allowed to Stall During the COVID-19 Pandemic
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
News Roundup / South Africa Pharma June 2020
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a…
Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when…
Medical Device Segment braced for change in South Africa
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device…
Tackling South Africa’s “Intimate Healthcare” Needs
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it…
South African Clinical Trials: Turning Diversity into Opportunity
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease…
Showcasing South African innovation
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem…
Interview: Andre Buhrlen – Managing Director, Hersol Manufacturing…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract…
Interview: Albert Denoon – Owner, Baroque Medical, – Board Member,…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit…
Interview: Charl De Klerk – General Manager, Bard South Africa
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa…
